NasdaqGM - Nasdaq Real Time Price USD
Merus N.V. (MRUS)
40.11
-0.81
(-1.98%)
As of 1:03:47 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| LUNDBERG SVEN ANTE Chief Executive Officer | Conversion of Exercise of derivative security | Apr 17, 2025 | 30,297 |
| SHUMAN HARRY Officer | Conversion of Exercise of derivative security | Mar 21, 2025 | 11,002 |
| SILVERMAN PETER B. Chief Operating Officer | Conversion of Exercise of derivative security | Jun 27, 2024 | 0 |
Related Tickers
ACLX Arcellx, Inc.
56.73
-2.61%
SRRK Scholar Rock Holding Corporation
30.90
-1.59%
NUVL Nuvalent, Inc.
70.77
-0.91%
RVMD Revolution Medicines, Inc.
39.70
-0.63%
PTGX Protagonist Therapeutics, Inc.
43.47
-1.81%
SNDX Syndax Pharmaceuticals, Inc.
9.65
-5.35%
CRNX Crinetics Pharmaceuticals, Inc.
30.93
-0.08%
MIRM Mirum Pharmaceuticals, Inc.
44.65
-1.37%
PCVX Vaxcyte, Inc.
29.29
-2.55%
APGE Apogee Therapeutics, Inc.
39.38
-0.92%